Complementary studies by Xu et al. highlighted modulation of protein kinase C (PKC) isoforms as an additional therapeutic mechanism, showing that arctiin inhibits hyperglycemia-induced diacylglycerol (DAG) accumulation and the resulting PKC activation [95,96]. The gene discussed is PRRT2; the disease is Hyperglycemia.